Authors
Latest:
Melphalan Flufenamide for Relapsed or Refractory Multiple MyelomaMelphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Latest:
Coming out of COVID: 5 Objectives for Boosting Rx Business and Cash Clinical ServicesOllin Sykes, CPA, CITP, and Scotty Sykes, CPA, CFP, discuss the business landscape after COVID within pharmacies and 5 objectives for focusing on growth again.
Latest:
Practice Update: Treating Patients Hospitalized With COVID-19Several institutions have published guidance on how to treat patients hospitalized with COVID-19.
Latest:
Review of FDA Approvals for Pediatric Obesity ManagementGLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Latest:
Detecting Crossover Symptoms of COVID-19, InfluenzaAs respiratory viruses and COVID-19 variants lurk seemingly everywhere, here’s how best to detect and differentiate.
Latest:
The Health Care Professional’s Role in Creating Equitable Patient OutcomesAn essay by Lord Simon Woolley that was published in BMJ calls on the medical community to speak up on how failed drug laws disproportionately harm black communities.
Latest:
Current and Future Treatments for Hidradenitis SuppurativaHidradenitis suppurativa is a chronic inflammatory skin condition that presents with painful, deep, and inflamed lesions found in flexural, apocrine gland-bearing sites.
Latest:
Pilot Program From Custom Health, L.A. Care, Tackles Medication AdherenceCustom is one of the growing number of companies focusing on adherence. It changed its name from Pack4U last year.
Latest:
Using Data to Put a Stop to Your Pharmacy's Profit LeakageTechnology will help you identify potential reimbursement problems before they trigger reduced payments or claims audits.
Latest:
FDA Accepts GSK's BLA for 5-in-1 Meningococcal VaccineThe company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Latest:
Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget CutsWith the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.
Latest:
Chewable Tablet Receives FDA Approval for Internal and External Parasites in DogsAfoxolaner, moxidectin, and pyrantel chewable tablets protect dogs from fleas, ticks, heartworm disease, roundworms, and hookworms.
Latest:
A Partnership to Optimize Medication Use and Patient OutcomesInitiative promotes adoption of value-based care models in community pharmacy settings.
Latest:
Sustaining Positivity Among Students, Professionals Critical for Pharmacy’s FutureA conversation with David Nau, PhD, professor of social and administrative pharmacy, and director of assessment at Ohio Northern University.
Latest:
COVID-19 Vaccines: A Focus on SafetyEase patients’ concerns by being well versed in the safety profiles of each vaccine.
Latest:
Health Care Affordability in the Election SpotlightMore than half of those who responded to a recent KFF survey say they are worried about paying for their prescription drugs.
Latest:
Q&A: Pharmacists Can Help Raise Awareness About CGMsHeather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM discuss challenges pharmacists may face when implementing CGM services and how they can help raise awareness.
Latest:
Guselkumab Phase 3 Data Show Sustained Skin Clearance After 5 YearsTremfya phase 3 data shows skin clearance rates were maintained at 5 years with 55.5% of patients achieving an IGA score of 0% and 53% achieving PASI 100 response in VOYAGE 2 trial.
Latest:
Vitamin D and COVID-19: An Evidence-Based ReviewIn this article, we will review the evidence describing a possible link between vitamin D and COVID-19.
Latest:
Recapping the FDA's Cancer Drug Approvals From The WinterHere’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.
Latest:
Is ChatGPT Health Care’s Next Big Thing?Artificial intelligence has many applications in health care, but hurdles to widespread adoption remain.
Latest:
Transparency in Drug Pricing Can Start With 340BThere are 3 key considerations in understanding 340B program results and benefits.
Latest:
The Pharmacist’s Role Beyond COVID-19Amid the pandemic, how effectively pharmacists embraced their role as frontline care providers could change the profession forever.
Latest:
Brexpiprazole Plus Sertraline for PTSD Submitted to FDA for sNDA ReviewTwo trials studying brexpiprazole in combination with sertraline "constitute one of the largest clinical development programs ever conducted in posttraumatic stress disorder (PTSD)."
Latest:
Q&A: How Bringing Medical Students Into the Pharmacy Can Enhance CollaborationRebecca Lahrman, PharmD, MS, BCACP discusses her time as a preceptor and what she learned from the experience.
Latest:
Lowering Patient Drug Costs with Biosimilars Can Happen When the Right Teams Come TogetherPharmacy benefit managers can help health plans understand when to best leverage and align to biosimilars and other cost-effective treatments.
Latest:
Type 1 Diabetes Management Can Improve With Goal SettingFindings from the FAMS-T1D study show that structured goal-setting and achievement significantly enhance self-efficacy and self-care in emerging adults.
Latest:
Basal Insulin Therapies for Diabetes ManagementDiana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Thomas C. Blevins, MD, ECNU, FACE, FNLA, review FDA-approved basal insulins for the management of diabetes.
